Organon & Co. (OGN) — Analysis Summary
Organon & Co. (OGN) has a market cap of $3.48B with year-over-year revenue growth of +2.2%. Net margin stands at 13.5%. The stock trades at a P/E ratio of 4.0.
Key Takeaways
- Revenue changed +2.2% year-over-year
- Net margin of 13.5%
- P/E ratio of 4.0
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, OGN posted revenue growth of +2.2% and trades at a P/E of 4.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.